Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonello Cabras

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Haematologica|July 22, 2021
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcomeAnna Dodero, Anna Guidetti, Fabrizio Marino, et al.
Blood|April 14, 2018
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphomaEnrico Tiacci, Erik Ladewig, Gianluca Schiavoni, et al.
Haematologica|August 21, 2020
A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphomaEnrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndromeDavide Rossi, Valeria Spina, Michaela Cerri, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Haematologica|July 22, 2021
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcomeAnna Dodero, Anna Guidetti, Fabrizio Marino, et al.
Blood|April 14, 2018
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphomaEnrico Tiacci, Erik Ladewig, Gianluca Schiavoni, et al.
Haematologica|August 21, 2020
A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphomaEnrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndromeDavide Rossi, Valeria Spina, Michaela Cerri, et al.
Pageof 3